Anti-fibrotic effects of cardiac progenitor cells in a 3D-model of human cardiac fibrosis

被引：0
|
作者：
Gartner, T. Bracco [1 ]
Deddens, J. C. [2 ]
Mol, E. A. [3 ]
Ferrer, M. M. [3 ]
Van Laake, L. W. [2 ]
Bouten, C. V. C. [4 ]
Khademhosseini, A. [5 ]
Suyker, W. J. L. [1 ]
Sluijter, J. P. G. [3 ]
Hjortnaes, J. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Cardiothorac Surg, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Expt Cardiol Lab, Utrecht, Netherlands
[4] Eindhoven Univ Technol, Dept Soft Tissue Biomech & Tissue Engn, Eindhoven, Netherlands
[5] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA
来源：
CARDIOVASCULAR RESEARCH | 2018年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P142
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [31] Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
    Cicko, Sanja
    Grimm, Melanie
    Ayata, Korcan
    Beckert, Jessica
    Meyer, Anja
    Hossfeld, Madelon
    Zissel, Gernot
    Idzko, Marco
    Mueller, Tobias
    RESPIRATORY RESEARCH, 2015, 16
  • [32] Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
    Mueller, Tobias
    Cicko, Sanja
    Idzko, Marco
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [33] Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
    Sanja Cicko
    Melanie Grimm
    Korcan Ayata
    Jessica Beckert
    Anja Meyer
    Madelon Hossfeld
    Gernot Zissel
    Marco Idzko
    Tobias Müller
    Respiratory Research, 16
  • [34] Epac is an integrator of pro-and anti-fibrotic signals in cardiac fibroblasts
    Aroonsakool, Nakon
    Yokoyama, Utako
    Patel, Hemal H.
    Lai, N. Chin
    Jennings, Michelle M.
    Roth, David M.
    FASEB JOURNAL, 2008, 22
  • [35] Development of a novel human 3D in vitro model for evaluating new anti-fibrotic drugs
    Woodrooffe, A.
    Freathy, C. S.
    Maitland, S. M.
    Baggot, K. L.
    Loraine, H. J.
    Murdock, P. R.
    TOXICOLOGY LETTERS, 2019, 314 : S177 - S177
  • [36] ANTI-FIBROTIC IMMUNE-MODULATION EFFECTS OF 25-HYDROXY-VITAMIN D IN HCV AND MICE FIBROSIS MODEL
    Doron, S.
    Amer, J.
    Abu-Tair, L.
    Mahamid, M.
    Abu-Mouch, S.
    Safadi, R.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S39 - S40
  • [37] Development of a Novel Human 3D in Vitro Model for Evaluating New Anti-Fibrotic Drugs
    Freathy, Caroline S.
    Maitland, Samantha M.
    Bagot, Kathryn L.
    Loraine, Howard J.
    Murdock, Paul R.
    Woodrooffe, Amanda
    HEPATOLOGY, 2018, 68 : 644A - 644A
  • [38] Intestinal organoids: A model of intestinal fibrosis for evaluating anti-fibrotic drugs
    Rodansky, Eva S.
    Johnson, Laura A.
    Huang, Sha
    Spence, Jason R.
    Higgins, Peter D. R.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2015, 98 (03) : 346 - 351
  • [39] Cyclosporin A has anti-fibrotic effects in human lung fibroblasts and in bleomycin-induced lung fibrosis model mice
    Yamazaki, Risa
    Fujita, Tetsuo
    Yanagihara, Madoka
    Nakamura, Hiroyuki
    Fujino, Hiromichi
    Kasuya, Yoshitoshi
    Murayama, Toshihiko
    FASEB JOURNAL, 2016, 30
  • [40] Effects of Anti-Fibrotic Drugs on Transcriptome of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis
    Ishii, Daisuke
    Kawasaki, Takeshi
    Sato, Hironori
    Tatsumi, Koichiro
    Imamoto, Takuro
    Yoshioka, Keiichiro
    Abe, Mitsuhiro
    Hasegawa, Yoshinori
    Ohara, Osamu
    Suzuki, Takuji
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
12345